Term ended May 26, 2026 · Medium confidence
20-year base term ended May 26, 2026
Why Medium: A parent in the chain could not be resolved.
Held by Aldeyra Therapeutics, Inc.
Filed Jan 3, 2018 as application 15/861,332 · Granted Feb 12, 2019
Base term, 20 years from filing
Today
Term ended May 26, 2026
2006
2026
Clock starts
May 26, 2006
May 26, 2006
Term ended
May 26, 2026
May 26, 2026
Granted
Feb 12, 2019
Feb 12, 2019
base term
after the term ends
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
10
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 26, 2006, when application 11/441,848, the earliest non-provisional in its chain, was filed (this one was filed Jan 3, 2018); a parent in its chain could not be resolved (the next row) | May 26, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | May 26, 2026 | Medium confidence |
This family
| US 7,973,025 | In force Jul 2028 | Jul 2028 |
| US 8,940,721 | In force no later than Jan 2027 | no later than Jan 2027 |
| US 9,265,759 | Term ended May 2026 | May 2026 |
| US 9,650,342 | Term ended May 2026 | May 2026 |
| US 9,896,419 | Term ended May 2026 | May 2026 |
| US 10,202,348 | this patent May 2026 | May 2026 |
| US 10,913,722 | Term ended Jun 2026 | Jun 2026 |
| US 11,724,987 | Term ended Aug 2026 | Aug 2026 |
8 of 10 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 3, 2019 Reel 47892, frame 298 | Jordan, Thomas A.; Dowling, John E.; Chabala, John Clifford | Neuron Systems, Inc. | Assignment of Assignor's Interest |
| Jan 3, 2019 Reel 48004, frame 258 | Neuron Systems, Inc. | Neuron Systems, Inc. | Change of Address |
| Jan 3, 2019 Reel 48007, frame 294 | Neuron Systems, Inc. | Aldexa Therapeutics, Inc. | Change of Name |
| Jan 3, 2019 Reel 48007, frame 346 | Aldexa Therapeutics, Inc. | Aldeyra Therapeutics, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
45
later US patents cite this one
That is top 5% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.